Skip to content

Usability study with the Melio leg bag system

Usability study with the Melio leg bag system: a non-randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN62635454
Enrollment
12
Registered
2014-01-21
Start date
2014-02-01
Completion date
Unknown
Last updated
2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal and Urogenital Urological and Genital Diseases Other specified urinary incontinence

Interventions

Participants will use the Melio leg bag system for 3 weeks. They will keep a diary of their experience with the bag during this time and complete a questionnaire at the end of the study.

Sponsors

Albert Medical Devices (UK)
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Males over 18 years of age who use external sheath drainage systems and patients of Rotherham NHS Foundation Trust continence service 2. Able to understand the Melio Leg bag system instruction for use and to complete the study questionnaire (they may have a carer who will assist with these activities) 3. Able to give written informed consent to participate

Exclusion criteria

Exclusion criteria: Patients whose need for a catheter is under active review

Design outcomes

Primary

MeasureTime frame
To assess whether end users find the novel features of the Melio leg bag system (a pump for emptying and a fill sensor) to be useful and reliable. The outcomes will be determined at the end of the study using a combination of a patient questionnaire which will be completed after patients have used the leg bag for three weeks, and diaries which participants will keep throughout the study.

Secondary

MeasureTime frame
To demonstrate the practicality of the Melio leg bag system in a self-use setting.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026